会員になる

カート (0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Baltimore Marriott Inner Harbor at Camden Yards

2013年4月03日 (水) 午前 8:15 - 2013年4月04日 (木) 午後 5:00

110 South Eutaw Street, Baltimore, MD 21201-1608

Regulatory Information Management 2013

戻る Agenda

Session 8A: Business Track - Implications of Working with FDA under FDASIA: A Primer for Successful Planning, Submission, and Approval of Applications

Session Chair(s)

Lisa Jenkins, PhD, MS

Vice President, Regulatory Strategy and Content Development

Virtual Regulatory Solutions, Inc, United States

In 2012, FDASIA (including PDUFA V, MDUFA III, and GDUFDA) was signed into law. This session describes and interprets the new provisions from an FDA and Industry perspective and makes strategic recommendations for multiple disciplines.

Speaker(s)

Kimberly Belsky, MS

Presenters

Kimberly Belsky, MS

Independent, United States

Reg Policy & Intell and AdPromo, Regulatory Affairs

Presenter

Ronald Trust, PhD, MBA

Pharmexpertise, LLC, United States

Independent Consultant